Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
All
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
Leaky pipe(lines) / When is a molecule a drug? (Part 1 of 2)
14 June 2022
Dear All, I was fascinated by this recent paper in AAC: Neha K. Prasad, Ian B. Seiple, Ryan T. Cirz, ...
Read More >
FDA/CVM: Antimicrobial use in companion animals
12 June 2022
Dear All, Post-newsletter addendum: I’ve learned that USDA will host a 10 Aug 2022 (virtual, 10a-4.30p ET) workshop on AMR in ...
Read More >
ATMF on Access in LMICs/Progress, but wishing for more
10 June 2022
Dear All, Last fall, the team at ATMF (Access to Medicine Foundation) released the 3rd update to the AMR Benchmark ...
Read More >
Climate change and AMR: NIH grant opportunity!
6 June 2022
Dear All, A Notice of Special Interest (a “NOSI” in NIH jargon; here’s the link: NOT-ES-22-006) from the NIH could be ...
Read More >
Notable reports: Incentives (WHO, AMR Hub); Strategy (BARDA); Capacity Building (UK Fleming Fund, US CDC)
4 June 2022
Dear All, Four big reports have recently been released and are very much worth reviewing. First, the Global AMR R&D ...
Read More >
Antibacterial guidance (including pediatrics): Parallel EMA+FDA updates
27 May 2022
Dear All (Wonkish alert! Get some coffee and settle in!), Almost in parallel, EMA and FDA have released updates to ...
Read More >
G7 Health Ministers: Pull incentives to support stewardship, access, and innovation
21 May 2022
Dear All, The G7 Health Ministers met 19-20 May 2022 in Berlin. As you might expect, their communique covered a ...
Read More >
CARB-X renewed x 10 years! Strong calls for PASTEUR!
19 May 2022
Dear All, On the heels of yesterday’s (i) patient-focused meeting at the Capitol yesterday where 5 Members of Congress spoke ...
Read More >
3 June 2022 FDA workshop: Developing for uncomplicated UTI (uUTI)
17 May 2022
Dear All, It doesn’t rain … it pours! Just seconds after sending out a newsletter on the 18 May et ...
Read More >
Starting 18 May: #SquashSuperbugs, Salt in My Soul (movie), and more!
17 May 2022
Dear All, Building on last year’s call from PFID to declare 18 May the annual “Squash Superbugs Day of Action,” we ...
Read More >
Meetings and more: Pandemic wargames! NIAID developer workshop! New stewardship prize!
11 May 2022
Dear All, As suggested by the subject line, this newsletter is a bit of a mish-mash of time-critical news about ...
Read More >
Job Opportunity In Berlin With Global AMR R&D Hub!
5 May 2022
Dear All, The Global AMR R&D Hub is looking for Head of the Global AMR R&D Hub Secretariat! The position would be ...
Read More >
Antibiotic supply chains: Challenges & Opportunities
4 May 2022
Dear All, In a report entitled Understanding the Antibiotic Manufacturing Ecosystem: A view of global supply chains, pressure points, and implications ...
Read More >
NIAID BAA To Support In Vitro Diagnostic Product Development
20 April 2022
Dear All, Excitingly, NIAID has released a new BAA (Broad Agency Announcement) entitled “Diagnostics Pre-Clinical Services Program.” Similar to the prior ...
Read More >
UK Pull (“Netflix-like”) pilot: STEDI-based QALY value of new antibiotics implies societal value > 10m GBP/year!
11 April 2022
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), We’ve written before about the UK’s “Netflix” pilot antibiotic ...
Read More >
ICARS seeks Executive Director
1 April 2022
Dear All, An interesting job listing for you today! The International Centre for Antimicrobial Resistance Solutions (ICARS) is looking for an ...
Read More >
Future Leaders Against AMR – Fireside Chat with Founder!
31 March 2022
Dear All, As some of you may have seen on Twitter, the Future Leaders Against AMR have been busy! I ...
Read More >
Pull mechanisms: Private capital can multiply Subscription (Netflix) and TEV models!
26 March 2022
Dear All: Three recent papers bring together an instructive perspective on Pull incentives for the #FireExtinguishersOfMedicine. The first two papers ...
Read More >
Comment on US 2023-2026 National Health Security Strategy
7 March 2022
Dear All, The US Office of the Assistant Secretary for Preparedness & Response (ASPR) is looking for comments on the 2023-2026 National Health ...
Read More >
Implementation Handbook on National Action Plans from WHO
3 March 2022
Dear All, Continuing on the theme of helping countries develop their own national action plans, WHO released the “WHO implementation ...
Read More >